• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Evercore Inc.

    11/20/24 5:35:04 PM ET
    $EVR
    Investment Managers
    Finance
    Get the next $EVR alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001323377
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Evercore Inc.
    SEC File Number
    001-32975
    Address of Issuer
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK
    NEW YORK
    10055
    Phone
    212-857-3100
    Name of Person for Whose Account the Securities are To Be Sold
    HYMAN EDWARD S
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Class A Common Stock
    Merrill Lynch
    225 Liberty St
    Floor 37
    New York � NY � 10281
    108553246674.713806874611/20/2024
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Class A Common Stock02/24/2022Conversion of limited partnership unitsEvercore Inc.Checkbox not checked1085502/24/2022Granted as part of issuer equity compensation plan

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/06/20245000015818997.51
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/07/20243410110531535.17
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/08/2024121623731331.09
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/12/2024103053177241.41
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/13/2024123163753365.23
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/14/2024108693261666.83
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/15/202485502550559.52
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/18/2024111543330077.97
    EDWARD HYMAN
    55 EAST 52ND STREET
    38TH FLOOR
    NEW YORK � NY � 10055
    Class A Common Stock11/19/202489862685669.94

    144: Remarks and Signature

    Remarks
    Date of Notice
    11/20/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    EDWARD HYMAN

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $EVR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVR

    DatePrice TargetRatingAnalyst
    1/26/2026$435.00Buy
    BofA Securities
    12/11/2025$340.00Neutral
    UBS
    12/8/2025$373.00Overweight → Equal-Weight
    Morgan Stanley
    10/9/2025$400.00Buy
    Deutsche Bank
    10/3/2025$358.00Market Perform
    BMO Capital Markets
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    6/23/2025$312.00Equal-Weight → Overweight
    Morgan Stanley
    4/8/2025$230.00Mkt Perform → Mkt Outperform
    Citizens JMP
    More analyst ratings

    $EVR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williamson Sarah K bought $580,860 worth of Shares of Class A common stock (2,000 units at $290.43), increasing direct ownership by 18% to 13,345 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    3/10/26 5:01:56 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Varney Christine A

    3 - Evercore Inc. (0001360901) (Issuer)

    3/20/26 4:31:48 PM ET
    $EVR
    Investment Managers
    Finance

    Director Williamson Sarah K bought $580,860 worth of Shares of Class A common stock (2,000 units at $290.43), increasing direct ownership by 18% to 13,345 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    3/10/26 5:01:56 PM ET
    $EVR
    Investment Managers
    Finance

    CEO/Chairman Weinberg John S was granted 31,528 units of Shares of Class A common stock, increasing direct ownership by 5% to 636,890 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    2/23/26 4:30:32 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Evercore Inc.

    SCHEDULE 13G/A - Evercore Inc. (0001360901) (Subject)

    3/26/26 6:22:31 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form 10-K filed by Evercore Inc.

    10-K - Evercore Inc. (0001360901) (Filer)

    2/20/26 4:51:14 PM ET
    $EVR
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Evercore Inc.

    SCHEDULE 13G/A - Evercore Inc. (0001360901) (Subject)

    2/10/26 11:21:52 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Evercore with a new price target

    BofA Securities initiated coverage of Evercore with a rating of Buy and set a new price target of $435.00

    1/26/26 10:01:23 AM ET
    $EVR
    Investment Managers
    Finance

    UBS resumed coverage on Evercore with a new price target

    UBS resumed coverage of Evercore with a rating of Neutral and set a new price target of $340.00

    12/11/25 9:08:53 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Evercore from Overweight to Equal-Weight and set a new price target of $373.00

    12/8/25 8:21:30 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group

    Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further

    3/12/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Wealth Management Promotes Sean Brady to Partner

    Evercore Wealth Management today announced the promotion of Sean Brady to partner. Mr. Brady is a wealth & fiduciary advisor at Evercore Wealth Management and its affiliate, Evercore Trust Company. "Sean is an experienced and thoughtful advisor," said Chris Zander, CEO of Evercore Wealth Management and Evercore Trust Company. "He is a strong contributor to our firm, able to manage complex planning challenges while always putting our clients first and working well within our unique team structure." Mr. Brady works with senior executives, private equity principals and families, delivering integrated strategic wealth planning and fiduciary services. He joined Evercore in 2024 from Clarfeld

    3/4/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Carpenter Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

    Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. "We are pleased to welcome Ben to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform." "We are excited to have Ben join the firm," said Francois Maisonrouge, chairman of Evercore's global healthcare group. "Biopharma is one of the most dynamic areas in global healthcare. Continuing to deepen our presence in this

    3/2/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Leadership Updates

    Live Leadership Updates

    View All

    David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group

    Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further

    3/12/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Carpenter Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

    Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. "We are pleased to welcome Ben to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform." "We are excited to have Ben join the firm," said Francois Maisonrouge, chairman of Evercore's global healthcare group. "Biopharma is one of the most dynamic areas in global healthcare. Continuing to deepen our presence in this

    3/2/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Hart Joins Evercore as Senior Managing Director and Head of Asia Private Capital Advisory

    Evercore (NYSE:EVR) announced today that Ben Hart has joined the firm as a senior managing director and head of its Asia Private Capital Advisory (PCA) division. Based in Singapore, Mr. Hart will oversee Evercore PCA's activities across the Asia-Pacific region and work closely with the global PCA team to further expand the firm's secondaries advisory and broader private markets capabilities in the region. "We are thrilled to welcome Ben to Evercore," said Nigel Dawn, global head of Evercore's PCA division. "Ben has built an exceptional reputation and deep relationships across Asia's private markets ecosystem. His extensive experience in capital formation and distribution across APAC will

    2/23/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Financials

    Live finance-specific insights

    View All

    Evercore Reports Record Fourth Quarter and Full Year 2025 Revenues; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Fourth Quarter Results   Full Year Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q4 2025 Q4 2024   Q4 2025 Q4 2024     2025     2024       2025     2024   Net Revenues ($ mm) $ 1,288.3   $ 975.3     $ 1,298.1   $ 980.5     $ 3,855.8   $ 2,979.6     $ 3,884.0   $ 3,002.6   Operating Income

    2/4/26 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 4, 2026

    Evercore (NYSE:EVR) will release its fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's fourth quarter and full year 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 245-3047 (to

    1/21/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Reports Third Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Third Quarter Results   Year to Date Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q3 2025 Q3 2024   Q3 2025 Q3 2024   YTD 2025 YTD 2024   YTD 2025 YTD 2024 Net Revenues ($ mm) $ 1,038.9   $ 734.2     $ 1,047.1   $ 739.5     $ 2,567.5   $ 2,004.3     $ 2,585.8   $ 2,022.1   Operating Income ($ mm) $ 216.2   $

    10/29/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evercore Inc.

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    10/4/24 2:32:45 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    2/13/24 5:04:33 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    7/10/23 10:41:25 AM ET
    $EVR
    Investment Managers
    Finance